# Clinical Performance Evaluation of DxN CMV Assay

> **NCT03127787** · — · TERMINATED · sponsor: **Beckman Coulter, Inc.** · enrollment: 19 (actual)

## Conditions studied

- Cytomegalovirus

## Interventions

- **DIAGNOSTIC_TEST:** CMV Assay

## Key facts

- **NCT ID:** NCT03127787
- **Lead sponsor:** Beckman Coulter, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2017-08-30
- **Final completion:** 2017-08-30
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2018-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03127787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03127787, "Clinical Performance Evaluation of DxN CMV Assay". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03127787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*